Internal Medicine · Defiance, OH
NPI
1588645394
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1400 E 2nd St
Defiance, OH, 43512
Phone (419) 784-1414
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
3,499 services
Medicare patients, 2024
1,028
Average age 76
Drug cost, 2024
$1.9M
26,182 prescriptions
Company payments, 2025
$417
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stavros R Karatsoridis was code 93010 (electrocardiogram), 1,578 times for 777 patients. In total Stavros R Karatsoridis billed 3,499 services in 28 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 1,578 | 777 | $5.70 | $8,995 |
| 99309 SNF E&M | Facility | 491 | 115 | $77.37 | $38K |
| 99214 Office E&M - Established | Facility | 426 | 185 | $63.51 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 215 | 137 | $11.73 | $2,522 |
| 93793 Care Management/Coordination | Facility | 151 | 22 | $8.24 | $1,244 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 141 | 141 | $121.60 | $17K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Facility | 138 | 138 | $21.53 | $2,971 |
| 99305 SNF E&M | Facility | 93 | 88 | $99.20 | $9,226 |
| 99213 Office E&M - Established | Facility | 67 | 54 | $43.31 | $2,902 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 24 | 19 | $37.17 | $892 |
| 99308 SNF E&M | Facility | 21 | 15 | $49.97 | $1,049 |
| 99215 Office E&M - Established | Facility | 21 | 18 | $103.39 | $2,171 |
| 99496 Chronic, Principal, and Transitional Care Management | Facility | 20 | 17 | $141.26 | $2,825 |
| 99495 Chronic, Principal, and Transitional Care Management | Facility | 18 | 16 | $105.46 | $1,898 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 11 | 11 | $155.93 | $1,715 |
By year: 2022 $131K for 3,547 services; 2023 $139K for 3,746 services; 2024 $124K for 3,499 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stavros R Karatsoridis prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,078 prescriptions and refills. In total Stavros R Karatsoridis wrote 26,182 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,078 | 1,533 | 115 | $9,298 |
| Atorvastatin Calcium Generic | 1,046 | 1,889 | 201 | $13K |
| Omeprazole Generic | 900 | 1,201 | 108 | $7,621 |
| Metoprolol Tartrate Generic | 532 | 867 | 103 | $4,154 |
| Lisinopril Generic | 526 | 1,057 | 116 | $3,512 |
| Furosemide Generic | 510 | 730 | 97 | $3,254 |
| Gabapentin Generic | 499 | 657 | 87 | $10K |
| Potassium Chloride Generic | 469 | 670 | 86 | $21K |
| Famotidine Generic | 460 | 560 | 52 | $4,634 |
| Baclofen Generic | 449 | 463 | 27 | $4,322 |
| Pantoprazole Sodium Generic | 441 | 602 | 61 | $7,123 |
| Tamsulosin Hcl Generic | 437 | 654 | 74 | $5,823 |
| Lamotrigine Generic | 420 | 436 | 16 | $3,656 |
| Divalproex Sodium Generic | 401 | 401 | 16 | $14K |
| Metformin Hcl Generic | 386 | 747 | 84 | $3,452 |
Brand drugs: 2,804 claims; generic drugs: 23,135 claims; opioid claims: 609.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stavros R Karatsoridis $417 ($417 in general payments such as food, travel and fees) from 15 companies. The largest payer was Amgen Inc. with $50.88.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 3 | $50.88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $45.3 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $43.8 |
| Novo Nordisk Inc NVO | 2 | $36.37 |
| Lilly USA, LLC LLY | 2 | $34.38 |
| Sequel Med Tech, LLC | 1 | $29.68 |
| Exact Sciences Corporation EXAS | 2 | $27.02 |
| Xeris Pharmaceuticals, Inc. | 1 | $24.51 |
| Ascensia Diabetes Care Us Inc. | 1 | $24.32 |
| Pfizer Inc. PFE | 1 | $19.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.